3 not yet recruiting. 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Not yet recruiting 3 |
Follow Urinary Bladder, Overactive: new trials by email Literature Review of Urinary Bladder, Overactive trials Research Report on Urinary Bladder, Overactive
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Non-invasive Saphenous Nerve Stimulation Therapy for Overactive Bladder Wearable neurostimulation system for saphenous nerve stimulation, tolterodine tartrate 4 mg extended release - Overactive Bladder (OAB) | Phase 3 | Not yet recruiting | NinaMED Pty Ltd | 290 | 2026-09-10 | 2026-08-24 |
| Efficacy of Gabapentin Combined With Solifenacin for Non-neurogenic Overactive Bladder in Women solifenacin combined with gabapentin, solifenacin monotherapy - Overactive Bladder | Phase 3 | Not yet recruiting | Mansoura University | 60 | 2026-02-01 | 2026-02-24 |
| The Effect of Nighttime Mirabegron, Solifenacin, Tolterodine, or Oxybutynin on Nocturia, Sexual Function, Autonomic Function, and Lower Urinary Tract Blood Flow Perfusion in Women With Overactive Bladder Syndrome: Randomized Controlled Trial Mirabegron 25mg, Solifenacin 5 mg, Tolterodine 4 mg - Urinary Bladder, Overactive | Phase 3 | Not yet recruiting | Far Eastern Memorial Hospital | 220 | 2025-08-07 | 2025-08-11 |
Nocturia (1)
Female Urogenital Diseases (3) · Female Urogenital Diseases and Pregnancy Complications (3) · Lower Urinary Tract Symptoms (3) · Male Urogenital Diseases (3) · Pathological Conditions, Signs and Symptoms (3) · Signs and Symptoms (3) · Urinary Bladder Diseases (3) · Urogenital Diseases (3) · Urologic Diseases (3) · Urological Manifestations (3)
Tolterodine Tartrate (2) · Gabapentin (1) · Solifenacin Succinate (1) · mirabegron (1)
Far Eastern Memorial Hospital (1) · Mansoura University (1) · NinaMED Pty Ltd (1)
Australia (1) · Egypt (1) · Taiwan (1) · United States (1)